MESA LABORATORIES INC CO
For the period ended Mar 31, 2025. Filed May 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Thefollowing of our directors or officers entered into written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule10b5-1(c) (each, a "trading arrangement") on the dates indicated:
Chief Financial Officer John Sakys entered into a trading arrangement on* March 3, 2025.The trading arrangement is effective through June 30, 2026,and contemplates that Mr. Sakys maysell 5,000 shares of Mesa Labs’ common stock, and further, mayexercise4,087* non-qualified stock options and sell the resulting4,087 shares of Mesa Labs' common stock, subject to certain conditions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.